Aaron Cox Takes on Chief Financial Officer Role at Galapagos
Galapagos, a leader in biotechnology, is thrilled to announce the appointment of Aaron Cox as Chief Financial Officer, effective July 7, 2025. This exciting addition to the leadership team comes as the company strives to enhance its growth and operational capabilities in the competitive biotech landscape.
Background of Aaron Cox
Aaron Cox joins Galapagos with an impressive background spanning over 20 years in corporate finance, strategic leadership, and business development. Most recently, he served as Executive Vice President and CFO at Horizon Therapeutics plc, where he made significant contributions, including steering the company through a $28 billion acquisition by Amgen. His extensive experience also includes pivotal roles in investment banking and corporate development.
Leadership Transition and Responsibilities
Cox will succeed Thad Huston, who will assist with the transition until the end of July 2025. As CFO, he will oversee Finance, Accounting, Tax, Procurement, Communications, and Investor Relations functions at Galapagos. His expertise in managing financial operations on a global scale is expected to play a crucial role in guiding the company’s innovative pipeline and strategic growth.
Commitment to Patient Outcomes
“We are delighted to welcome Aaron to Galapagos,” said CEO Henry Gosebruch. “His experience and leadership will be essential as we focus on accelerating our pipeline growth and managing our resources to improve patient outcomes worldwide.” Galapagos continues to uphold its mission to address high unmet medical needs through science-driven solutions, and with Aaron's leadership, the company is confident in making impactful advancements.
Aaron's Vision for the Future
Expressing his enthusiasm, Aaron shared, “Joining Galapagos at this pivotal moment is incredibly exciting. I look forward to collaborating with Henry and the exceptional team to create shareholder value and deliver meaningful innovations that benefit patients.” His commitment to enhancing patient care and familiarity with the biotechnology sector align perfectly with Galapagos’s vision for the future.
Educational Background
Aaron holds a Bachelor’s degree in Finance from the University of Notre Dame and an MBA from the University of Chicago Booth School of Business, which have provided him with a strong foundation for his successful career in finance and corporate leadership.
About Galapagos
Galapagos is at the forefront of biotechnology, dedicated to improving patient lives through life-changing innovations. With operations across Europe, the U.S., and Asia, the company focuses on developing a robust pipeline of therapies that target significant unmet medical needs. By integrating leading scientific research and cutting-edge technology, Galapagos is reshaping the future of healthcare and ensuring that its groundbreaking treatments reach those in need.
The leadership changes and strategic decisions made by Galapagos demonstrate a commitment to empowering their team and advancing their mission to create impactful healthcare solutions. Through strong governance and innovative development, Galapagos is poised for continued success in the biotechnology sector.
Frequently Asked Questions
1. Who is the new CFO of Galapagos?
Aaron Cox has been appointed as the new Chief Financial Officer of Galapagos, effective July 7, 2025.
2. What experience does Aaron Cox bring to Galapagos?
Aaron Cox brings over 20 years of experience in corporate finance, business development, and biotech leadership, including a significant role at Horizon Therapeutics.
3. What will be Aaron Cox's responsibilities as CFO?
As CFO, Aaron will manage Finance, Accounting, Tax, Procurement, Communications, and Investor Relations at Galapagos and will work closely with company leadership to enhance the organization’s strategic goals.
4. Who did Aaron Cox succeed?
Aaron Cox succeeds Thad Huston, who will remain at Galapagos until July 31, 2025, to facilitate a smooth transition.
5. What is the mission of Galapagos?
Galapagos aims to transform patient outcomes through innovative science and effective healthcare solutions, focusing on addressing unmet medical needs worldwide.
